Quantbot Technologies’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-824
| Closed | -$76K | – | 2212 |
|
|
2021
Q4 | $76K | Sell |
824
-505
| -38% | -$33.3K | 0.01% | 939 |
|
|
2021
Q3 | $79K | Sell |
1,329
-1,832
| -58% | -$108K | 0.01% | 1018 |
|
|
2021
Q2 | $215K | Buy |
+3,161
| New | +$206K | 0.02% | 731 |
|
|
2021
Q1 | – | Sell |
-1,628
| Closed | -$125K | – | 1885 |
|
|
2020
Q4 | $125K | Buy |
+1,628
| New | +$122K | 0.01% | 699 |
|
|
2020
Q1 | – | Sell |
-815
| Closed | -$37K | – | 1562 |
|
|
2019
Q4 | $37K | Buy |
815
+215
| +36% | +$10.2K | ﹤0.01% | 992 |
|
|
2019
Q3 | $27K | Sell |
600
-500
| -45% | -$28.1K | ﹤0.01% | 1080 |
|
|
2019
Q2 | $64K | Buy |
+1,100
| New | +$56.9K | 0.01% | 850 |
|
|
2018
Q3 | – | Sell |
-369
| Closed | -$16K | – | 1649 |
|
|
2018
Q2 | $16K | Sell |
369
-3,549
| -91% | -$153K | ﹤0.01% | 1092 |
|
|
2018
Q1 | $154K | Buy |
3,918
+2,574
| +192% | +$100K | 0.01% | 749 |
|
|
2017
Q4 | $45K | Buy |
1,344
+546
| +68% | +$15.6K | ﹤0.01% | 992 |
|
|
2017
Q3 | $20K | Buy |
+798
| New | +$18.3K | ﹤0.01% | 1059 |
|
Quantbot Technologies's ARNA Position: Q1 2022 in Review
Quantbot Technologies sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 824 shares — an estimated $76K sold.
Quantbot Technologies first reported a position in ARNA in Q3 2017 and held it in 11 quarters. The position peaked at $215K in Q2 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Quantbot Technologies reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Quantbot Technologies sold 824 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $76K.
- Quantbot Technologies first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 11 quarters.
- Quantbot Technologies's Arena Pharmaceuticals Inc position peaked at $215K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Quantbot Technologies's 13F filing for Q1 2022, filed 16 May 2022.